Tesla Energy

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Enphase (ENPH) surges 17% on FCC draft ban of foreign solar inverters

Enphase (ENPH) +17% on FCC draft ban of foreign solar inverters. Chinese Sungrow, Huawei face US lockout; ENPH's AI data center pivot gets tailwind.

byVenkatesh

July 1, 2026

Representative image of South Korea battery makers reshaping North America strategy as LG Energy Solution, Samsung SDI, and SK On pivot from EV battery overcapacity toward energy storage systems and LFP expansion after the US electric vehicle market slowdown.

Korean battery makers pivot to grid storage as US BEV sales collapse

LG Energy Solution, Samsung SDI and SK On are converting US EV battery plants to grid storage as the American BEV market contracts sharply after federal tax credits expired.

byVenkatesh

April 19, 2026

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Enphase (ENPH) surges 17% on FCC draft ban of foreign solar inverters

Korean battery makers pivot to grid storage as US BEV sales collapse

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

SAMILBIO expands Chaeyun skincare with two November launches as K-beauty exports reach $11.1bn

Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?

Haleon (HLN) near 319p: Does a 15% share-price crash make its valuation attractive after the growth downgrade?

Ethan Allen will split CEO and chair roles, but who gets to choose Farooq Kathwari’s successor?